Serum Institute to start Mfg Sputnik vaccine in September

The parties intend to produce over 300 million doses of the vaccine in India per year, it added.

48
Medicine Injection Vaccine
Picture: Pixabay

Last Updated on July 15, 2021 by The Health Master

Serum Institute of India (SII) will start production of Sputnik vaccine at the company’s facilities in September, Russian Direct Investment Fund (RDIF) said today.

“The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September,” RDIF said in a statement.

The parties intend to produce over 300 million doses of the vaccine in India per year, it added.

“As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center. With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun,” RDIF said.

Latest Notifications: EC Act (Essential Commodities Act)

NPPA fixes retail prices of 11 formulations

NABL: List of NABL Accredited Testing Laboratories

Abbott launches C-19 Home Test Kit in India

FDC launches Favipiravir oral suspension

Alert: Various chemicals in Cosmetics: Must read

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner